News

The team, led by Professor Seong-Seng Tan at Melbourne’s Howard Florey Institute, has discovered that this naturally occurring protein, called BP5, is produced more than usual in brain

Barr confirmed that J&J unit Janssen Pharmaceutica NV, the holder of the Razadyne new drug application, and Synaptech, the holder of the patent, had filed the suit against

The pivotal study will include approximately 162 non-Hodgkin’s lymphoma (NHL) patients who are refractory to rituximab in combination with chemotherapy or to rituximab given as maintenance treatment. “NHL

Under the agreement, Takeda has received exclusive worldwide rights to develop, manufacture and market the HuL2G7 antibody. Takeda will pay Galaxy an upfront licensing fee of $2 million,

These patients will be enrolled from approximately six clinical sites in the US and given interferon or placebo for four weeks to assess the effect of treatment on

The University of Alabama in Huntsville (UAH) brought litigation against Nektar and Dr Milton Harris, a former employee of the university, claiming that the company’s portfolio of products

The data from the recently completed trial showed that Sanctura XR met its primary endpoints, reduction in frequency of urination and reduction in number of urge incontinence episodes.

The grant, awarded through the small business innovation research (SBIR) program, will support phase II safety and efficacy studies of PMI-150 in a multicenter, randomized, double blind, and

The companies said that the restructuring is mutually beneficial based upon a review of each company’s long-term business strategies and objectives. The restructured agreement will allow Wyeth to